CANVA
Canva, a world leader in visual communication with more than 190 million monthly active users, today announced plans to acquire Leonardo.AI. As one of Australia’s fastest-growing startups, and a leading generative AI content and research company, Leonardo.AI is empowering millions of people to bring their ideas to life through production-quality images and videos. The acquisition complements Canva's offering and enhances the company’s vision to build a world-class suite of visual AI tools, marking this as an important milestone in its AI journey.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729977410/en/
Canva will acquire Leonardo.AI, a leading generative AI content and research company (Graphic: Business Wire)
As AI continues to shape the future of work and visual communication, the acquisition will accelerate Canva’s investment in continued research and development while bringing Leonardo’s cutting-edge foundational model to Canva’s community worldwide. From creating assets for marketing and advertising campaigns, to visualizing stunning interior concepts, refining mockups, and producing dynamic videos, Leonardo’s technology has been used to produce more than one billion images in the last 18 months.
For Leonardo.AI this is an opportunity to produce new levels of AI innovation while also growing the organisation’s scale. With Canva’s support, the company’s current trajectory will be supercharged to build an even more creative-centric generative AI platform globally.
“We’re thrilled to welcome Leonardo.AI to Canva - two Australian companies joining forces to bring world-first breakthroughs in AI and creativity," said Cameron Adams, co-founder and Chief Product Officer of Canva. “This field is constantly evolving, and Leonardo’s technical leadership and community impact can’t be overstated. Bringing our worlds together will accelerate each of our teams' work, taking us from strength to strength, and we can’t wait to get started.”
World Leading Generative AI Capabilities
Founded in late 2022, Leonardo’s foundational model empowers millions of people to turn ideas into production-quality visual assets with unprecedented control, speed and style consistency. Creators can generate images in any chosen aesthetic in seconds with simple prompts, create videos, sketch with AI, and custom-train models with their own datasets.
Leonardo's new foundational model, Phoenix, takes creator control to the next level, with unprecedented prompt adherence, coherent, accurate text in images and the ability to generate production-ready assets in one shot.
“Today marks the start of a new chapter which will accelerate the pace we innovate at Leonardo.Ai,” said JJ Fiasson, Founder and CEO, Leonardo.AI. Joining the Canva family means we can invest more deeply in scaling our AI research efforts globally, and move even faster to deliver new features and functionality to creatives worldwide.”
In less than two years since launching, Leonardo.AI has amassed more than 19 million registered users and is used across a wide variety of industries including advertising, marketing, design, entertainment, architecture, fashion, e-commerce and education. The joint effort with Canva will produce new levels of AI technology to not only engage, but to also grow Leonardo’s fast growing user base.
From hobbyists to film directors, architects, and professional designers, Leonardo’s technology delivers advanced creative control that pushes the boundaries of what’s possible in generative AI, while remaining intuitive and accessible. Its models can generate stunning images in styles ranging from strikingly realistic photos to character portraits, anime, painterly styles, and more, while its AI video generation tools can bring almost any concept to dynamic life.
Reimagining Visual Communication
Canva’s recent Visual Economy Report shows that the need for effective, efficient, and compelling visual communication has surged dramatically. AI is now playing an increasingly important role in elevating both productivity and creativity at work. From marketing teams scaling global campaigns by instantly generating ad creative for specific audiences, to designers creating initial drafts and storyboards, generative artificial intelligence is changing the way work gets done.
Leonardo’s world-class technology and foundational model will supercharge Canva’s mission to empower every kind of professional to turn their ideas into designs in an instant, leading to faster, more innovative, and more compelling visual communication.
Leonardo's technology will complement Canva’s Magic Studio, the company’s suite of AI tools, which has been used more than 7 billion times since it launched in 2023. To date, Canva users have elevated their design and creative output leveraging Magic Studio for everything from summarising documents to creating images and turning brainstorm whiteboards into fully-fledged presentations.
Supercharging Canva’s AI Journey
Canva will continue to invest in Leonardo's standalone platform while integrating its technology throughout the company’s suite of Magic Studio products. Working with Leonardo’s team of 120 high-caliber researchers, engineers, and designers will also bolster Canva’s research and development capabilities as the company continues to invest in long-term innovation opportunities.
Acquisitions have played an important role in elevating and accelerating Canva’s technology over the last decade. The acquisition of Leonardo is the company’s 8th acquisition, joining Affinity (2024), Flourish (2022), Kaleido (2021), Smartmockups (2021), Pexels (2019), Pixabay (2019) and Zeetings (2018).
For more details about the acquisition, see Canva Co-Founder Cameron Adams blog post and Leonardo.Ai’s CEO JJ Fiasson’s blog post, respectively.
About Canva
Launched in 2013, Canva is a free online visual communications and collaboration platform with a mission to empower everyone in the world to design. Featuring a simple drag-and-drop user interface and a vast range of templates ranging from presentations, documents, websites, social media graphics, posters, apparel to videos, plus a huge library of fonts, stock photography, illustrations, video footage, and audio clips, anyone can take an idea and create something beautiful.
About Leonardo.Ai
Leonardo.Ai is one of Australia’s fastest-growing startups, democratising creativity with its generative AI content production platform. Since launching in 2022, the company has amassed more than 19 million users worldwide, who have generated over one billion images. Leonardo.Ai is currently being used by both hobbyists and professionals across creative industries such as advertising and marketing, design and architecture, film, fashion, photography, e-commerce, education, and more.
Downloadable Assets
Click here
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240729977410/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lazard Appoints Edouard Panié as Managing Director and Co-Head of European Financial Sponsors Coverage20.10.2025 08:00:00 CEST | Press release
Lazard, Inc. (NYSE: LAZ) today announced the appointment of Edouard Panié as Managing Director and Co-Head of the European Financial Sponsors Coverage. He will report to Klaus H. Hessberger, Global Co-Head and Head of Europe for Lazard’s Financial Sponsors Group, to further strengthen the firm’s presence and partnerships with financial sponsors across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019307537/en/ Edouard Panié Mr. Panié joins from Goldman Sachs, where he was a Managing Director for nearly two decades, advising on more than 60 landmark M&A, debt, and equity transactions for leading alternative asset managers in private equity, growth equity, and infrastructure, as well as entrepreneurs, families, and corporates. “Private capital is playing an increasingly pivotal role in shaping industries and driving growth. Edouard’s extensive experience and relationships will strengthen Lazard’s ability to pro
Lone Star Announces Sale of Xella to Holcim20.10.2025 06:40:00 CEST | Press release
Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund X, LP of a binding agreement to sell Xella Group (“Xella”), a leading provider of walling solutions, to Holcim, the leading partner for sustainable construction. The transaction values Xella at approximately €1.85 billion. Headquartered in Duisburg, Germany, Xella is a European provider of efficient and sustainable walling solutions for the entire house shell, operating brands such as Ytong, Silka, Hebel and Multipor. The company employs more than 4,000 team members. In partnership with Lone Star, Xella has taken significant strides in recent years to optimize its offering by strategically focusing the business on walling solutions, while also enhancing its commercial and digital capabilities. Under Lone Star’s stewardship, Xella has also continued to progress its sustainability initiatives. Today, the business stands as a market leader in its sector with a strong reputation for a people-first c
Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform and Announces Introduction of Multiple New Products20.10.2025 06:00:00 CEST | Press release
Biedermann Motech, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced the market introduction of several additions to its MOSS!MODULARITY™ platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019799867/en/ MOSS!MODULARITY Injection Screw MOSS!MODULARITY encompasses a broad range of products and technologies for spinal surgery based around the concept of providing an advanced modular workflow for posterior stabilization and deformity correction. The modular workflow allows surgeons to place the headless bone screw shafts as a first step, without the tulip heads attached, and offers several advantages over working with traditional pre-assembled pedicle screws, e.g.: Improved visualisation and access to the surgical working space; Precise decompression, decortication and osteotomies without any interference with polyaxial tulip heads; Increased surgic
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 19:30:00 CEST | Press release
Data presented at ESMO 2025 show INCA33890, a TGFβR2×PD-1 bispecific antibody, has the potential to be an effective treatment in microsatellite stable (MSS) colorectal cancerPlanned initiation of registrational program for INCA33890 in MSS colorectal cancer in 2026Maturing data for INCB161734, a KRAS G12D inhibitor, shows a favorable safety profile and evidence of clinical benefit in heavily pre-treated pancreatic ductal adenocarcinoma (PDAC) patientsIncyte will expand on the results from the oral presentations at an in-person and webcasted event on Sunday, October 19, 2025, from 1:30 – 3:00 p.m. EDT (7:30 – 9:00 p.m. CEST) Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment19.10.2025 11:15:00 CEST | Press release
New data from pivotal Phase 3 ROSELLA trial reinforce relacorilant plus nab-paclitaxel improves progression-free and overall survival in patients with platinum-resistant ovarian cancer, with no need for biomarker selection – including in people who progressed while on or after taking a PARP inhibitor, a patient population with particularly poor prognosis Corcept expands BELLA trial to three study arms: (i) platinum-resistant ovarian cancer, (ii) platinum-sensitive ovarian cancer and (iii) endometrial cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom